Product Images Pirfenidone

The text provides a figure showing the Cumulative Distribution of Patients based on the Change in Percent Predicted FVC from Baseline to Week 52 in Study 1. The dashed lines represent a decline of greater than 10% or 20%. The figure illustrates the percentage of patients experiencing worsening (%FVC decrease) and those with no decline (increase in %FVC) over the specified period.*

This text provides a dosing schedule for Pirfenidone Tablets 267 mg, indicating the number of pills to be taken in the morning, afternoon, and evening for each week. The schedule is outlined for days 1 to 7, days 8 to 14, and from day 15 onward, specifying the total pills to be consumed each day.*

This text provides information on the dosing schedule for Pirfenidone Tablets 801 mg starting from day 15 onward. The recommended schedule is to take 1 tablet in the morning with breakfast, 1 tablet in the afternoon with lunch, and 1 tablet in the evening with dinner, totaling 3 pills each day.*

The text contains information about a medication called Pirfenidone Tablets, USP. The tablet contains 267 mg of the active ingredient and is distributed by Aurobindo Pharma USA, Inc. The address of the company is 278 Princeton-Hightstown Road, East Windsor, NJ 08520. The usual dosage instructions can be found in the package insert. The tablets are made in India and should be stored at 20°C to 25°C. It is important to keep the medication out of reach of children. The text also includes a code for the drug and information about the quantity of tablets per package.*

This is a description of a medication called Pirfenidone Tablets, USP, which comes in a bottle containing 270 tablets (3 bottles of 90 tablets each). Each tablet contains 267 mg of Pirfenidone USP. The packaging includes a unique serial number and 2D data matrix on each carton for tracking purposes. The usual dosage information can be found in the package insert. It is important to keep this medication out of reach of children and store it at 20° to 25°C (68° to 77°F). This medication is distributed by Aurobindo Pharma USA, Inc. and is manufactured in India.*

This text provides information about Pirfenidone tablets containing 801 mg and distributed by Aurobindo Pharma USA, Inc. The tablets are labeled with the NDC code 59651-239-90 and manufactured in India. It advises to keep the tablets out of reach of children and store them at a temperature between 20°C to 25°C (68°F to 77°F). The packaging includes dosage instructions and a specific code for identification.*

This text is a description of Pirfenidone Tablets, USP in a pack of 90 tablets. It includes information on dosage, storage instructions, NDC number, and details about the manufacturer. The tablets contain 801 mg of Pirfenidone USP and are distributed by Aurobindo Pharma USA, Inc. It also mentions the unique serial number on each carton with a 2D data matrix printed during packing.*